Tsai Jaw-ji, director of the Department of Allergy and Clinical Immunology at Cathay General Hospital, has developed a nasal spray based on synthesized dust-mite protein fragments combined with an immune-response-boosting extract of enoki mushrooms, which is not only effective in combating airway inflammation, but is also considerably safer than traditional desensitization treatment. The nasal spray is currently in the human trial stage.
此外，國泰醫院過敏免疫科主任蔡肇基，研發以合成的塵 (蛋白片段，加上具有增強免疫功效的金針菇淬取液，合成為鼻滴劑，不但具有抗呼吸道發炎的功效，同時也沒有傳統減敏療法引發過敏的風險，安全性較高，目前也即將進入人體實驗階段。